Company information:
Denceptor Therapeutics Limited (No: 09661368)
Address: ABZENA HOLDINGS LIMITED, BABRAHAM RESEARCH CAMPUS, BABRAHAM, CAMBRIDGE, CB22 3AT
Status: Active
Incorporated: 29-Jun-2015
Accounts Next Due: 31-Dec-2019
Next Confirmation Statement Due: 04-Feb-2020
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: RICHARD HENRY JOHN MILBANK ( DOB: Dec-1964 From: Nov-2018 )
Current Director: MICHELLE DAWN NEAVES ( DOB: May-1976 From: Sep-2018 )
Current Secretary: MICHELLE DAWN NEAVES ( From: Sep-2018 )
Resigned Director: CAMPBELL BUNCE ( DOB: Aug-1970 From: Jul-2016 To: Sep-2018 )
Resigned Director: WILLIAM JOHN EDWARD BURT ( DOB: Jul-1968 From: Sep-2018 To: Oct-2018 )
Resigned Director: KEVIN JOHN FITZGERALD ( DOB: Mar-1964 From: Jul-2016 To: Dec-2017 )
Resigned Director: JULIAN MATTHEW SMITH ( From: Jul-2015 To: Sep-2018 )
Resigned Director: BRADLEY JAMES THEOBALD ( DOB: Jan-1973 From: Jun-2015 To: Jul-2015 )
Resigned Director: SALLY CHRISTINA WATERMAN ( DOB: Jun-1958 From: Jul-2015 To: Jul-2016 )
Resigned Secretary: JULIAN MATTHEW SMITH ( From: Jul-2015 To: Sep-2018 )
Persons of Significant Control:
Abzena Holdings Limited, Babraham Research Campus Babraham, Cambridge, CB22 3AT, United Kingdom: Ownership of shares – 75% or more, Ownership of voting rights - 75% or more, Right to appoint and remove directors (Notified: 2016-04-06)